-
Mashup Score: 27FDA Approves Novel Treatment for Chronic Graft-Versus-Host-Disease | Leukemia and Lymphoma Society - 3 month(s) ago
FDA Approves Novel Treatment for Chronic Graft-Versus-Host-Disease > Page Components
Source: www.lls.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 2Volunteer | Leukemia and Lymphoma Society - 3 month(s) ago
Changing lives. Changing the world. At The Leukemia & Lymphoma Society (LLS), we celebrate the people who give their time and energy to the blood cancer community—our volunteers. And we’re giving a big shout out for everything they do—whether it’s supporting a patient over the phone, interning with us, advocating for policy change, or participating in local fundraising events, our volunteers are truly the heart of LLS. By continually helping people you don’t know and those you do—and by helping to raise
Source: www.lls.orgCategories: General Medicine News, Partners & KOLsTweet-
Ready to support our mission? Learn how you can get involved 👉 https://t.co/jhNYwiPaxM
-
-
Mashup Score: 5Dare to Dream Project: Treating Kids with Blood Cancer | LLS - 3 month(s) ago
We’re daring to improve the quality of life for every child with blood cancer, daring to dream of them thriving. Find out more about the Leukemia and Lymphoma Society!
Source: www.lls.orgCategories: General Medicine News, Partners & KOLsTweet-
With the Dare the Dream Project, we're spearheading this global effort to transform treatment and care for young adults with #BloodCancer like Yaneiry. The details 👉 https://t.co/p4qmahYfsj https://t.co/TJoTdmbfyS
-
-
Mashup Score: 7Latest FDA Approval Demonstrates Improved Response Times in Multiple Myeloma | Leukemia and Lymphoma Society - 4 month(s) ago
Latest FDA Approval Demonstrates Improved Response Times in Multiple Myeloma > Page Components
Source: www.lls.orgCategories: General Medicine News, Partners & KOLsTweet-
🚨 The @US_FDA has approved a drug combo for patients with newly diagnosed multiple myeloma who are eligible for an autologous stem cell transplant. Discover how this combo provided patients in a clinical trial longer remissions 👉 https://t.co/4wk6ArfhYP https://t.co/X2PwX1YQpJ
-
-
Mashup Score: 3Information Specialists | Leukemia and Lymphoma Society - 4 month(s) ago
Information Specialists > Page Components
Source: www.lls.orgCategories: General Medicine News, Partners & KOLsTweet-
Sending lots of ❤️ and support to all those facing pediatric blood cancer. We’re here for you, committed to transforming treatment and care for kids with blood cancer. Reach out for support today 👉 https://t.co/6lsASFIzEu
-
-
Mashup Score: 7LLS teams up with advocates to advance policies that protect patients from medical debt | Leukemia and Lymphoma Society - 4 month(s) ago
LLS teams up with advocates to advance policies that protect patients from medical debt > Page Components
Source: www.lls.orgCategories: General Medicine News, Oncologists1Tweet-
🎉Over the last year, @llsusa helped secure new laws in 10 states that will protect patients from medical debt – a financial burden they face through no fault of their own. Learn more about how patients will benefit from the new laws ⬇️ https://t.co/sveNxrTNVD https://t.co/IGtGRKd8IT
-
-
Mashup Score: 26FDA Approves Targeted Immunotherapy for Aggressive Forms of Follicular Lymphoma | Leukemia and Lymphoma Society - 4 month(s) ago
FDA Approves Targeted Immunotherapy for Aggressive Forms of Follicular Lymphoma > Page Components
Source: www.lls.orgCategories: General Medicine News, Partners & KOLsTweet-
The @US_FDA has approved a new targeted immunotherapy for adults with relapsed or refractory follicular #lymphoma. Learn more 👉 https://t.co/LR0ME5azL2 https://t.co/4rboyFJTVA
-
-
Mashup Score: 9
Young Advocate, Big Goals: Charlotte’s Story > Page Components
Source: www.lls.orgCategories: General Medicine News, Partners & KOLsTweet-
✨ Stop the scroll! ✨ Meet Charlotte! This young advocate is turning dreams into reality and making it her mission for other kids with #BloodCancer to have easier access to care. This is a must read 👉 https://t.co/9CyuKXf6sl https://t.co/SN8fm6Hpc4
-
-
Mashup Score: 15FDA Approves Immunotherapy for Earlier Use in B-cell Acute Lymphoblastic Leukemia | Leukemia and Lymphoma Society - 4 month(s) ago
FDA Approves Immunotherapy for Earlier Use in B-cell Acute Lymphoblastic Leukemia > Page Components
Source: www.lls.orgCategories: General Medicine News, Partners & KOLsTweet-
Big news for blood cancer patients! 🎉 The @US_FDA has approved a new treatment for earlier use in B-cell acute lymphoblastic leukemia (B-ALL). This immunotherapy offers new hope for all ages 👉 https://t.co/87WhG4pNi6 https://t.co/0nPRICITfI
-
-
Mashup Score: 1Improving Blood Cancer Survival Takes More than New Drug Discovery | Leukemia and Lymphoma Society - 5 month(s) ago
By Gwen Nichols, MD, LLS Chief Medical Officer | July 10, 2024 In my years as a practicing hematologist-oncologist and now as chief medical officer of The Leukemia & Lymphoma Society (LLS), I’ve met many blood cancer patients who worry about how they’ll afford their treatment on top of day-to-day expenses like rent and grocerie s. LLS offers financial assistance for qualifying blood cancer patients and families to help them through difficult times, but the dollars we provide can feel like just a drop in
Source: www.lls.orgCategories: General Medicine News, Partners & KOLsTweet-
___% of patients exhaust their entire life savings within two years of a cancer diagnosis. Discover how the LLS Equity in Access program is changing the face of blood cancer care 👉 https://t.co/hG0JUknGJ5
-
Promising news for blood cancer patients! ❤️ The @US_FDA recently approved a new treatment for chronic graft-versus host disease (cGvHD) in children and adults 👉 https://t.co/jbBSfTgwDC https://t.co/078Co7HfEg